Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈÇÐȸ Á¦11Â÷ International Congress on Lipid & Atherosclerosis (ICoLA 2022) 1ÀÏÂ÷ : 2022-09-15±³À°ÀÏÀÚ : 2022-09-15
±³À°Àå¼Ò : ¿©Àǵµ ÄÜ·¡µå È£ÅÚ
±³À°ÁÖÁ¦ :
Á¦11Â÷ International Congress on Lipid & Atherosclerosis (ICoLA 2022) 1ÀÏÂ÷ÁÖÃÖ±â°ü : Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈÇÐȸ
´ã´çÀÚ : ICoLA2022 »ç¹«±¹
¿¬¶ôó : 02-2285-2507
À̸ÞÀÏ :
secretariat@icola2022.org ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 11 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 140,000¿ø
ºñ°í Àü¹®ÀÇ, ±³¼ö : »çÀüµî·Ï 120,000¿ø / ÇöÀåµî·Ï 140,000¿øÀüÀÓÀÇ, Àü°øÀÇ,Çлý µî : »çÀüµî·Ï 60,000¿ø / 70,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-15 Room 1 12:00~12:30 Atorvastatin with Ezetimibe Combination Therapy for Very High/High Risk Groups Seung-Pyo Lee(Seoul National University, Korea)
Åä·Ð 09-15 Room 1 12:30~12:40 Discussion ()
±³À°½Ã°£ 09-15 Room 2 12:00~12:30 How to manage cardiovascular Health with Atorvastation in Patients Hyungdon Kook(Hanyang University, Korea)
Åä·Ð 09-15 Room 2 12:30~12:40 Discussion ()
±³À°½Ã°£ 09-15 Room 1 12:50~13:10 How much treatable residual risk do we really have? Bo Kyung Koo(Seoul National University, Korea)
±³À°½Ã°£ 09-15 Room 1 13:10~13:30 Concept of multiple risk factor control in DM Hyun Min Kim(Chung-Ang University, Korea)
±³À°½Ã°£ 09-15 Room 1 13:30~13:50 Is there special tool for control of diabetic dyslipidemia? Nam Hoon Kim(Korea University, Korea)
Åä·Ð 09-15 Room 1 13:50~14:15 Discussion ()
±³À°½Ã°£ 09-15 Room 2 12:50~13:10 Cellular lipid trafficking & cholesterol homeostasis Young Mi Park(Ewha Womans University, Korea)
±³À°½Ã°£ 09-15 Room 2 13:10~13:30 Identification of novel lipid droplet factors in macrophage foam cells Mireille Ouimet(University of Ottawa, Canada)
±³À°½Ã°£ 09-15 Room 2 13:30~13:50 Nutrient sensing mechanism for LDLR related protein LRP6 Eek-hoon Jho(University of Seoul, Korea)
Åä·Ð 09-15 Room 2 13:50~14:15 Discussion ()
±³À°½Ã°£ 09-15 Room 3 12:50~13:10 Biological & clinical influence of air pollution on metabolism & vasculature Seung-Pyo Lee(Seoul National University, Korea)
±³À°½Ã°£ 09-15 Room 3 13:10~13:30 Role of T-cell cholesterol efflux pathways in aging, inflammation, & atherosclerosis Marit Westerterp(University of Groningen, Netherlands)
±³À°½Ã°£ 09-15 Room 3 13:30~13:50 Circadian rhythm as risk & treatment target in ASCVD Mahmood Hussain(New York University, USA)
Åä·Ð 09-15 Room 3 13:50~14:15 Discussion ()
±³À°½Ã°£ 09-15 Room 4 12:50~13:10 MAFLD & risk of cardiovascular disease Yong-ho Lee(Yonsei University, Korea)
±³À°½Ã°£ 09-15 Room 4 13:10~13:30 PDK, NAFLD, & ASCVD Jae-Han Jeon(Kyungpook National University, Korea)
±³À°½Ã°£ 09-15 Room 4 13:30~13:50 Recent evidence between CVD & NAFLD/NASH in Japan Masahiro Koseki(Osaka University, Japan)
Åä·Ð 09-15 Room 4 13:50~14:15 Discussion ()
ÈÞ½Ä 09-15 14:20~14:30 Coffee Break ()
±³À°½Ã°£ 09-15 Room 1 15:30~15:50 Calcium score to predict future CV event Eun-Jung Rhee(Sunkyunkwan University, Korea)
±³À°½Ã°£ 09-15 Room 1 15:50~16:10 What are unsolved issues in the coronary CT research? Iksung Cho(Yonsei University, Korea)
±³À°½Ã°£ 09-15 Room 1 16:10~16:30 New markers of coronary CT for future CV event Min Jae Cha(Chung-Ang University, Korea)
Åä·Ð 09-15 Room 1 16:30~16:55 Discussion ()
±³À°½Ã°£ 09-15 Room 2 15:30~15:50 Role of TCF21 disease gene in SMC phenotype modulation Juyong Kim(Stanford University, USA)
±³À°½Ã°£ 09-15 Room 2 15:50~16:10 Targeting SMC phenotypic switching in vascular disease Chang Seon Myung (Chungnam National University, Korea)
±³À°½Ã°£ 09-15 Room 2 16:10~16:30 Regulation of phenotypic plasticity of vascular smooth muscle cells Sun Sik Bae(Pusan National University, Korea)
Åä·Ð 09-15 Room 2 16:30~16:55 Discussion ()
±³À°½Ã°£ 09-15 Room 4 15:30~15:50 The Next Step in Stroke Prevention : Beyond Lowering LDL Cholesterol Yong Jae Kim(The Catholic University of Korea, Korea)
±³À°½Ã°£ 09-15 Room 4 15:50~16:10 Lipid management for patients with non-atherosclerotic stroke Woo-Keun Seo(Sunkyunkwan University, Korea)
±³À°½Ã°£ 09-15 Room 4 16:10~16:30 Target LDL-C level for patients with cerebrovascular disease Kazuo Kitagawa(Tokyo women medical hospital, Japan)
Åä·Ð 09-15 Room 4 16:30~16:55 Discussion ()